Aurinia制药 AUPH 深 沪
等待开盘 11-05 09:30:00 美东时间
14.27
+1.100
+8.35%
华盛通- 最 高16.20
- 今 开13.50
- 成交量 519.88万股
- 最 低 13.50
- 昨 收 13.17
- 总市值 18.84亿
- 52周最高 16.20
- 市盈率 静 363.10
- 换手率 3.94%
- 52周最低 6.55
- 委 比 -1.33%
- 总股本 1.32亿
- 历史最高 33.972
- 量 比 2.58
- 振 幅 20.50%
- 历史最低 1.41
- 每 手 1
- 风险率 1.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Aurinia Pharmaceuticals Raises FY2025 Sales Guidance from $260.000M-$270.000M to $275.000M-$280.000M vs $270.478M Est
Aurinia Pharmaceuticals (NASDAQ:AUPH) raises FY2025 sales outlook from $260.000 million-$270.000 million to $275.000 million-$280.000 million vs $270.478 million estimate.
11-04 19:01
Aurinia Pharmaceuticals Q3 EPS $0.23 Beats $0.16 Estimate, Sales $73.468M Beat $67.418M Estimate
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.16 by 43.75 percent. This is a 130 percent increase over earnings of $0.10 per share
11-04 19:00
FDA Drug Chief George Tidmarsh Resigns After Allegations Of Power Misuse
FDA drug center head George Tidmarsh resigned after accusations of misusing power to harm a former business associate. He denies wrongdoing.
11-03 19:58
Aurinia Pharmaceuticals to Present New LUPKYNIS Data on Lupus Nephritis at ACR and ASN Conferences
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) today announced that five posters will be presented in collaboration with independent investigators highlighting new data on LUPKYNIS® (voclosporin) at the American College
10-15 18:02
Aurinia responds after top FDA official’s comment on lead drug
Aurinia Pharmaceuticals (NASDAQ:AUPH) traded ~7% higher in the premarket on Tuesday after the company responded to a comment made by a top FDA regulator regarding its lead drug Lupkynis, also known as...
09-30 19:08
Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction
Aurinia Pharmaceuticals ( ($AUPH) ) has issued an announcement. Aurinia Pharmac...
09-30 09:08
Aurinia Pharmaceuticals Raises FY2025 Sales Guidance from $250.00M-$260.00M to $260.00M-$270.00M vs $258.52M Est
Aurinia Pharmaceuticals (NASDAQ:AUPH) raises FY2025 sales outlook from $250.00 million-$260.00 million to $260.00 million-$270.00 million vs $258.52 million estimate.
07-31 18:01
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
